These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 12105234
21. Cardiovascular events and COX-2 inhibitors. Singh G. JAMA; 2001 Dec 12; 286(22):2810-1; author reply 2811-2. PubMed ID: 11735748 [No Abstract] [Full Text] [Related]
24. [Dorsopathia in the practice of a therapist--new possibilities of the treatment]. Shostak NA. Ter Arkh; 2003 Apr 12; 75(12):59-61. PubMed ID: 14959473 [No Abstract] [Full Text] [Related]
25. Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs. Daoud KF, Jackson CG, Williams HJ. Compr Ther; 1999 Apr 12; 25(8-10):427-33. PubMed ID: 10520445 [Abstract] [Full Text] [Related]
27. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy. Celotti F, Durand T. Prostaglandins Other Lipid Mediat; 2003 Jul 12; 71(3-4):147-62. PubMed ID: 14518558 [Abstract] [Full Text] [Related]
28. Effect of nonsteroidal anti-inflammatory drugs on osteogenesis and spinal fusion. Reuben SS. Reg Anesth Pain Med; 2001 Jul 12; 26(6):590-1. PubMed ID: 11707804 [No Abstract] [Full Text] [Related]
30. [Safe use of anti-inflammatory analgesics]. Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society. Duodecim; 2003 Jul 12; 119(22):2167-71. PubMed ID: 14702803 [No Abstract] [Full Text] [Related]
32. COX-2--selective NSAIDs. Hutchison R. Am J Nurs; 2004 Mar 12; 104(3):52-5; quiz 55-6. PubMed ID: 15108571 [No Abstract] [Full Text] [Related]
33. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution. Noroian G, Clive D. Drug Saf; 2002 Mar 12; 25(3):165-72. PubMed ID: 11945113 [Abstract] [Full Text] [Related]
34. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary]. MMW Fortschr Med; 2001 Oct 18; 143(42):64. PubMed ID: 11697296 [No Abstract] [Full Text] [Related]
35. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. Gambaro G, Perazella MA. J Intern Med; 2003 Jun 18; 253(6):643-52. PubMed ID: 12755960 [Abstract] [Full Text] [Related]
36. The perioperative use of cyclooxygenase-2 selective nonsteroidal antiinflammatory drugs may offer a safer alternative. Reuben SS, Connelly NR. Anesthesiology; 2004 Mar 18; 100(3):748. PubMed ID: 15109000 [No Abstract] [Full Text] [Related]
37. Dual inhibition of cyclo-oxygenases and 5-lipoxygenase: a novel therapeutic approach to inflammation? Naveau B. Joint Bone Spine; 2005 May 18; 72(3):199-201. PubMed ID: 15850989 [No Abstract] [Full Text] [Related]
38. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs. Atkinson HG. Health News; 2002 Aug 18; 8(8):5. PubMed ID: 12206146 [No Abstract] [Full Text] [Related]
39. Renal effects of nonselective NSAIDs and coxibs. Weir MR. Cleve Clin J Med; 2002 Aug 18; 69 Suppl 1():SI53-8. PubMed ID: 12086295 [Abstract] [Full Text] [Related]